Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDL
5801
Super Hi International Holding
HDL
$753M
| $110K | ﹤0.01% |
5,003
+3
| +0.1% | +$74 |
|
|
KOOL
5802
North Shore Equity Rotation ETF
KOOL
$60M
| $110K | ﹤0.01% |
+10,649
| New | +$116K |
|
|
TBLU
5803
Tortoise Global Water ETF
TBLU
$58.3M
| $109K | ﹤0.01% |
2,299
| – | – |
|
5804
Alpha Tau Medical
DRTS
$1.23B
| $109K | ﹤0.01% |
43,341
+390
| +0.9% | +$1.22K |
|
5805
Civeo
CVEO
$330M
| $109K | ﹤0.01% |
4,728
-5,321
| -53% | -$124K |
|
5806
Ultralife
ULBI
$116M
| $109K | ﹤0.01% |
20,196
-22,640
| -53% | -$154K |
|
5807
Hartford Schroders Tax-Aware Bond ETF
HTAB
$291M
| $109K | ﹤0.01% |
5,660
+205
| +4% | +$3.96K |
|
5808
Gyre Therapeutics
GYRE
$713M
| $108K | ﹤0.01% |
14,030
-1,211
| -8% | -$13.3K |
|
5809
GeoVax Labs
GOVX
$3.93M
| $108K | ﹤0.01% |
4,087
+4,082
| +81,640% | +$180K |
|
5810
Zura Bio
ZURA
$535M
| $108K | ﹤0.01% |
83,909
-30,199
| -26% | -$47.6K |
|
|
CLLS
5811
Cellectis
CLLS
$278M
| $108K | ﹤0.01% |
86,795
-111,899
| -56% | -$166K |
|
|
PAMT
5812
PAMT Corp
PAMT
$287M
| $108K | ﹤0.01% |
8,863
-6,076
| -41% | -$87.6K |
|
5813
SB Financial Group
SBFG
$166M
| $107K | ﹤0.01% |
5,148
+2,495
| +94% | +$53.1K |
|
5814
Comp X International
CIX
$374M
| $107K | ﹤0.01% |
5,171
-1,118
| -18% | -$26.8K |
|
5815
ProShares Ultra Semiconductors
USD
$2.8B
| $107K | ﹤0.01% |
5,304
-2,640
| -33% | -$75.7K |
|
|
HNW
5816
DELISTED
Pioneer Diversified High Income Fund
HNW
| $107K | ﹤0.01% |
8,960
+402
| +5% | +$4.8K |
|
5817
Strive US Energy ETF
DRLL
$298M
| $107K | ﹤0.01% |
3,593
-480
| -12% | -$13.8K |
|
5818
AMCON Distributing
DIT
$67.2M
| $107K | ﹤0.01% |
1,362
+150
| +12% | +$12.9K |
|
|
PPSI
5819
Pioneer Power Solutions
PPSI
$32.1M
| $106K | ﹤0.01% |
35,592
+18,553
| +109% | +$67.3K |
|
5820
Innovator Defined Wealth Shield ETF
BALT
$2.79B
| $106K | ﹤0.01% |
3,383
+3,038
| +881% | +$95.9K |
|
5821
Actinium Pharmaceuticals
ATNM
$24.2M
| $106K | ﹤0.01% |
65,758
-150,376
| -70% | -$191K |
|
|
MRSN
5822
DELISTED
Mersana Therapeutics
MRSN
| $106K | ﹤0.01% |
12,285
-35,849
| -74% | -$553K |
|
5823
Cytosorbents Corp
CTSO
$22.7M
| $106K | ﹤0.01% |
105,707
-918
| -0.9% | -$967 |
|
5824
Werewolf Therapeutics
HOWL
$18.6M
| $105K | ﹤0.01% |
107,827
-30,315
| -22% | -$39.7K |
|
5825
Seres Therapeutics
MCRB
$50.2M
| $105K | ﹤0.01% |
7,480
-93,183
| -93% | -$1.46M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.